WO2002062981A1 - A yeast human immunoregulator and the method for preparing it - Google Patents

A yeast human immunoregulator and the method for preparing it Download PDF

Info

Publication number
WO2002062981A1
WO2002062981A1 PCT/CN2001/000114 CN0100114W WO02062981A1 WO 2002062981 A1 WO2002062981 A1 WO 2002062981A1 CN 0100114 W CN0100114 W CN 0100114W WO 02062981 A1 WO02062981 A1 WO 02062981A1
Authority
WO
WIPO (PCT)
Prior art keywords
genes
yeast
specific
cell
regulate
Prior art date
Application number
PCT/CN2001/000114
Other languages
French (fr)
Chinese (zh)
Inventor
Kamfu Wong
Original Assignee
Six Forest Bio-Science Institute Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Six Forest Bio-Science Institute Limited filed Critical Six Forest Bio-Science Institute Limited
Priority to PCT/CN2001/000114 priority Critical patent/WO2002062981A1/en
Publication of WO2002062981A1 publication Critical patent/WO2002062981A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations

Abstract

The present invention relatives to a method for activating ordinary yeast recessive genes by employing simulated life electromagnetic wave information to make the ordinary yeast into specific yeast, wherein the specific proteins (enzymes) expressed by the specific yeast respectively have the functions to activate, regulate, correct the B cell immune genes, T cell immune genes, K cell immune genes and NK cell variant genes of low immunological competence. The specific yeast was made into biological preparation to regulate the body immune genes for reconstructing the body immune function and recovering the body health from several diseases. The present biological preparation can be used in prevention and treatment to various tumors, uraemia, hapatitis, presbyophrenia, various gastrointestinal diseases, diabetes, neural disturbance and the like, which have significant effect and no toxic or side effect.
PCT/CN2001/000114 2001-02-08 2001-02-08 A yeast human immunoregulator and the method for preparing it WO2002062981A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000114 WO2002062981A1 (en) 2001-02-08 2001-02-08 A yeast human immunoregulator and the method for preparing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000114 WO2002062981A1 (en) 2001-02-08 2001-02-08 A yeast human immunoregulator and the method for preparing it

Publications (1)

Publication Number Publication Date
WO2002062981A1 true WO2002062981A1 (en) 2002-08-15

Family

ID=4574768

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000114 WO2002062981A1 (en) 2001-02-08 2001-02-08 A yeast human immunoregulator and the method for preparing it

Country Status (1)

Country Link
WO (1) WO2002062981A1 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8402388A (en) * 1983-08-01 1985-03-01 Shigezo Udaka MEDICINAL PRODUCT SPF-100 AND METHOD FOR PREPARING THE SAME
SU1174475A1 (en) * 1984-02-10 1985-08-23 Предприятие П/Я А-1067 Method of processing brewer's yeast
SU1592328A1 (en) * 1988-05-16 1990-09-15 Ki T I Pishchevoj Promy Method of activating bakery yeasts
EP0615757A1 (en) * 1993-03-18 1994-09-21 Georges Serge Grimberg New therapeutic composition having an immunostimulant effect

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8402388A (en) * 1983-08-01 1985-03-01 Shigezo Udaka MEDICINAL PRODUCT SPF-100 AND METHOD FOR PREPARING THE SAME
SU1174475A1 (en) * 1984-02-10 1985-08-23 Предприятие П/Я А-1067 Method of processing brewer's yeast
SU1592328A1 (en) * 1988-05-16 1990-09-15 Ki T I Pishchevoj Promy Method of activating bakery yeasts
EP0615757A1 (en) * 1993-03-18 1994-09-21 Georges Serge Grimberg New therapeutic composition having an immunostimulant effect

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy

Similar Documents

Publication Publication Date Title
WO2002062981A1 (en) A yeast human immunoregulator and the method for preparing it
WO2002062983A1 (en) A yeast with t cell immunoregulatory activity as well as the preparing method and the uses thereof
WO2002062985A1 (en) A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof
WO2002062984A1 (en) The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof
WO2004092405A3 (en) Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
WO2002062982A1 (en) A yeast having b cell immune regulation activity and its preparation method and application thereof
WO2002074156A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2002092001A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2006031363A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2003031650A3 (en) Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease
WO2003037267A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2003089575A3 (en) Antibodies that specifically bind to tl5
WO2004007667A3 (en) Polynucleotide and polypeptide fat metabolism regulators and uses thereof
WO2003031572A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
EP2116616A3 (en) Genes differentially expressed in activated T cells and uses thereof
WO2003025010A3 (en) Human delta-n p73 molecules and uses thereof
WO2003076578A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002074921A3 (en) Methods for isolating proteins expressed by dendritic cells
WO1998051782A3 (en) Human 3-hydroxyisobutyryl-coenzyme a hydrolase
WO2003028536A3 (en) Methods for diagnosing and treating heart disease
WO2004074514A3 (en) Method of diagnosis of type 2 diabetes and early onset thereof
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
WO2001089548A3 (en) Pharmaceutical use of fibulin-1
WO2004076613A3 (en) Human nucleic acid sequences from carcinomas of the bladder

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP